Healing & Repair
KLOW (5/5/25/5)
A four-peptide healing blend pairing BPC-157 and TB-500 with the anti-inflammatory tripeptides GHK-Cu and KPV; investigated as a single-injection convenience format for connective-tissue research.
Quick facts
Molecular weight
1,419 Da
Half-life
4 h
Frequency
daily
Admins / wk
7
Routes
SubQ
Typical dose
250 mcg–500 mcg
Mechanism & positioning
A four-peptide healing blend pairing BPC-157 and TB-500 with the anti-inflammatory tripeptides GHK-Cu and KPV; investigated as a single-injection convenience format for connective-tissue research.
Researched for: tissue repair, anti-inflammatory signalling, wound healing.
Blend composition
Reconstitution defaults
Default vial
40 mg
BAC water
3 mL
Concentration
13333 mcg/mL
Doses per vial
~160
Calculate with this peptide
Related peptides in the Healing & Repair class
Frequently asked questions about KLOW (5/5/25/5)
What is the typical research dose range for KLOW (5/5/25/5)?
KLOW (5/5/25/5) is most commonly investigated at 250 mcg–500 mcg per administration, daily. Note: per BPC-157 component; other components scale proportionally. These values reflect documented research-stage protocols and are not medical recommendations.
What is the half-life of KLOW (5/5/25/5)?
KLOW (5/5/25/5) has an approximate plasma half-life of 4 hours. Practical steady state is reached after roughly five half-lives — about 1 days under continuous administration.
How is KLOW (5/5/25/5) administered in research protocols?
Published research uses subq administration. Typical reconstitution is 40 mg vial in 3 mL of bacteriostatic water, producing a concentration of 13333 mcg/mL.
What vial sizes are commonly available for KLOW (5/5/25/5)?
Common stocked vial sizes are 40 mg. The 40 mg vial is the most-used default in published protocols.